Emilio Martín Mola-rekin lankidetzan egindako argitalpenak (4)

2013

  1. Comparative effects of teriparatide and risedronate in glucocorticoid- induced osteoporosis in men: 18-month results of the EuroGIOPs trial

    Journal of Bone and Mineral Research, Vol. 28, Núm. 6, pp. 1355-1368

  2. Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis

    Osteoporosis International, Vol. 24, Núm. 12, pp. 2971-2981

2008

  1. Fracture incidence and changes in quality of life in women with an inadequate clinical outcome from osteoporosis therapy: The Observational Study of Severe Osteoporosis (OSSO)

    Osteoporosis International, Vol. 19, Núm. 4, pp. 493-501

2006

  1. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: The Observational Study of Severe Osteoporosis (OSSO)

    QJM, Vol. 99, Núm. 8, pp. 531-543